<DOC>
	<DOCNO>NCT02090465</DOCNO>
	<brief_summary>Assessment treatment success quality life patient actinic keratoses therapy Ingenol Mebutate ( Picato ) period 8 week .</brief_summary>
	<brief_title>Assessment Treatment Success Quality Life Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate Period 8 Weeks</brief_title>
	<detailed_description>Non-interventional ( observational ) study ( NIS ) , non-controlled , prospective cohort study .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>• Nonhyperkeratotic , nonhypertrophic actinic keratoses treatment Picato® indicate treatment intend physician . Preceding use Picato® area plan treatment Any specific local treatment actinic keratoses area plan treatment last 8 week Melanoma , squamous cell carcinoma spinalioma area plan treatment Open wound area plan treatment Contraindications accord prescribe information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Actinic Keratosis</keyword>
</DOC>